Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

Keynote webinar | Spotlight on medication adherence

LIVE: Thursday 27th June 2024, 18:00-19:30 (CEST)
Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.
ADVANCED SEARCH
Log in
Top
Rheumatology International
Published in: Rheumatology International 7/2013

01-07-2013 | Letter to the Editors

Posterior ischemic optic neuropathy in a patient with granulomatosis with polyangiitis (Wegener’s)

Authors: Takao Nagashima, Kazuko Matsumoto, Takamasa Murosaki, Mari Okada, Masahiro Iwamoto, Shinji Makino, Seiji Minota

Published in: Rheumatology International | Issue 7/2013

Login to get access

Excerpt

Dear Editor, …
Literature
1.
Pakrou N, Selva D, Leibovitch I (2006) Wegener’s granulomatosis: ophthalmic manifestations and management. Semin Arthritis Rheum 35:284–292PubMedCrossRef
2.
Sadda SR, Nee M, Miller NR, Biousse V, Newman NJ, Kouzis A (2001) Clinical spectrum of posterior ischemic optic neuropathy. Am J Ophthalmol 132:743–750PubMedCrossRef
3.
Moubayed SP, Black DO (2009) Optic neuritis as an initial presentation of Wegener’s granulomatosis. Can J Ophthalmol 44:e59PubMedCrossRef
4.
Belden CJ, Hamed LM, Mancuso AA (1993) Bilateral isolated retrobulbar optic neuropathy in limited Wegener’s granulomatosis. J Clin Neuroophthalmol 13:119–123PubMedCrossRef
5.
Shunmugam M, Morley AM, Graham E, D’Cruz D, O’Sullivan E, Malhotra R (2011) Primary Wegener’s granulomatosis of the orbital apex with initial optic nerve infiltration. Orbit 30:24–26PubMedCrossRef
6.
Paul B, McElvanney AM, Agarwal S, Bruckner FE, Ayliffe W (2002) Two rare causes of posterior ischaemic optic neuropathy: eosinophilic fasciitis and Wegener’s granulomatosis. Br J Ophthalmol 86:1066–1068PubMedCrossRef
7.
Blaise P, Robe-Collignon N, Andris C, Rakic JM (2007) Wegener’s granulomatosis and posterior ischemic optic neuropathy: Atypical associated conditions. Eur J Intern Med 18:326–327PubMedCrossRef
8.
Hayreh SS, Podhajsky PA, Zimmerman B (1998) Ocular manifestations of giant cell arteritis. Am J Ophthalmol 125:509–520PubMedCrossRef
Metadata
Title
Posterior ischemic optic neuropathy in a patient with granulomatosis with polyangiitis (Wegener’s)
Authors
Takao Nagashima
Kazuko Matsumoto
Takamasa Murosaki
Mari Okada
Masahiro Iwamoto
Shinji Makino
Seiji Minota
Publication date
01-07-2013
Publisher
Springer-Verlag
Published in
Rheumatology International / Issue 7/2013
Print ISSN: 0172-8172
Electronic ISSN: 1437-160X
DOI
https://doi.org/10.1007/s00296-012-2427-z

Other articles of this Issue 7/2013

Rheumatology International 7/2013 Go to the issue

Original Article

The effect of TNF-alpha blockers on psychometric measures in ankylosing spondylitis patients: a preliminary observation

Original Article

Major trends in the manifestations and treatment of rheumatoid arthritis in a multiethnic cohort in Singapore

Original Article

Renal involvement in ankylosing spondylitis: prevalence, pathology, response to TNF-a blocker

Original Article

Combination of MTX and LEF attenuates inflammatory bone erosion by down-regulation of receptor activator of NF-kB ligand and interleukin-17 in type II collagen-induced arthritis rats

Review

Pulmonary hypertension in rheumatic diseases: epidemiology and pathogenesis

Review

Anti-citrullinated protein antibodies: role in pathogenesis of RA and potential as a diagnostic tool
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Reserve your place

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

Read more

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Pediatric Cardiology Video

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

Cardiopulmonary Comorbidity Video

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Valvular Heart Disease Video

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Heart Failure Video

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.

ACC 2024 Congress Coverage

Year in Review: Heart failure and cardiomyopathies

Heart Failure Video

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.

Watch now

Semaglutide benefits people with type 2 diabetes and obesity-related heart failure

16-04-2024 Type 2 Diabetes News

Incentivised to exercise

11-04-2024 Lifestyle Modifications News

New intervention for STEMI-related cardiogenic shock

10-04-2024 Myocardial Infarction News

» View more highlights on the ACC 2024 congress hub page

Image Credits